Treatment Options for Post-Prandial Hypotension

Non-Pharmacological Management

The European Society of Cardiology recommends implementing smaller, more frequent meals with reduced carbohydrate content to minimize post-prandial blood pressure drops 1, 2
Ensure adequate hydration and salt intake, targeting 2-3 L of fluids per day and 10 g of NaCl, as suggested by the European Heart Journal 2, 3
Rapid cool water ingestion before meals can effectively combat post-prandial hypotension, according to the European Heart Journal 2, 3
Consider liquid calories in greater proportion for easier digestion, as recommended by the American Diabetes Association 4
Use abdominal binders and/or compression stockings to reduce venous pooling, as suggested by the European Heart Journal 1, 2, 3
Implement physical countermeasures such as leg crossing and squatting during symptoms, as recommended by the European Heart Journal 2, 3
Sleep with the head of the bed elevated (10°) to maintain more favorable fluid distribution, as suggested by the European Heart Journal 2, 3
Encourage judicious exercise of leg and abdominal muscles, especially swimming, as recommended by the European Heart Journal 1, 2

Midodrine (5-20 mg, three times daily) is FDA-approved and should be considered first-line therapy for post-prandial hypotension, with the last dose at least 3-4 hours before bedtime, as recommended by the European Heart Journal 2, 5
Fludrocortisone (0.1-0.3 mg once daily) stimulates renal sodium retention and expands fluid volume, as suggested by the European Heart Journal 2, 3, 5
Octreotide can be considered for severe post-prandial hypotension, as recommended by the European Heart Journal 2, 3

For patients with both hypertension and post-prandial hypotension, consider administering antihypertensive medications at bedtime, as suggested by the American Diabetes Association 4, 6
When selecting antihypertensive medications for patients with post-prandial hypotension, prefer long-acting dihydropyridine calcium channel blockers or RAS inhibitors, as recommended by the European Society of Cardiology 7
For diabetic patients, consider underlying autonomic neuropathy as a cause and optimize glucose control, as suggested by the American Diabetes Association 4, 5
For elderly patients, start with lower doses and titrate more gradually, as recommended by the European Society of Cardiology 5